Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Capital Expenditures (2020 - 2024)

Historic Capital Expenditures for Celularity (CELUW) over the last 5 years, with Q4 2024 value amounting to $1.4 million.

  • Celularity's Capital Expenditures rose 38310.81% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year increase of 4312.98%. This contributed to the annual value of $1.5 million for FY2024, which is 4312.98% up from last year.
  • Latest data reveals that Celularity reported Capital Expenditures of $1.4 million as of Q4 2024, which was up 38310.81% from $31000.0 recorded in Q2 2024.
  • Celularity's 5-year Capital Expenditures high stood at $9.4 million for Q4 2020, and its period low was -$258000.0 during Q3 2023.
  • Over the past 5 years, Celularity's median Capital Expenditures value was $1.2 million (recorded in 2021), while the average stood at $1.5 million.
  • In the last 5 years, Celularity's Capital Expenditures tumbled by 11650.67% in 2023 and then soared by 38310.81% in 2024.
  • Celularity's Capital Expenditures (Quarter) stood at $9.4 million in 2020, then tumbled by 75.43% to $2.3 million in 2021, then plummeted by 66.17% to $779000.0 in 2022, then crashed by 62.0% to $296000.0 in 2023, then soared by 383.11% to $1.4 million in 2024.
  • Its Capital Expenditures stands at $1.4 million for Q4 2024, versus $31000.0 for Q2 2024 and $39000.0 for Q1 2024.